Patients deserve straight answers, not hype and not willful ignorance
Many clients feel more energetic, see skin improvements, and feel better overall
While Eli Lilly and Company provides warning labels about common side effects of their tirzepatide medications, their labels may not have provided adequate warnings about severe health risks such as stomach paralysis, intestinal blockages, bowel obstruction, or frequent and excessive vomiting
Furthermore, this review primarily focuses on the bacterial component of the gut microbiome, which represents the most extensively investigated domain in relation to GLP-1 receptor agonist therapy
Medicare GLP-1 Bridge program (July to December 2026) To address the growing demand while long-term policies are finalized, the federal government has introduced a temporary Bridge program for the second half of 2026